Structure-activity relationships of endothelin-1 analogues

Area of Science:

• Pharmacology
• Molecular Biology
• Endocrinology

Background:

• Endothelin-1 (ET-1) is a potent vasoconstrictor peptide.
• Understanding ET-1's structure-activity relationship is crucial for developing targeted therapeutics.
• Specific residues are known to influence ET-1's interaction with its receptors.

Purpose of the Study:

• To investigate the functional importance of residues 9 and 10 in ET-1's biologic activity.
• To characterize the receptor interactions of ET-1 analogues [Ala9]-ET-1 and [Ala10]-ET-1.
• To evaluate the potential of FCE27037 as an ETB receptor antagonist.

Main Methods:

• Studied guinea pig ileum responses to ET-1 analogues ([Ala9]-ET-1, [Ala10]-ET-1) and known receptor ligands.
• Utilized ETA antagonist BQ-123 to differentiate receptor pathways.
• Performed cross-tachyphylaxis and additivity studies.
• Assessed the effect of FCE27037 on IRL1620-induced responses.

Main Results:

• [Ala9]-ET-1 mimicked ET-1's activity at ETA receptors with similar potency and efficacy.
• [Ala10]-ET-1 acted as a partial agonist at ETB receptors, distinct from ET-1's ETA activity.
• Lysine at position 9 is critical for ET-1-induced tachyphylaxis.
• FCE27037 selectively inhibited the contractile component of IRL1620 response, identifying it as an ETB antagonist.

Conclusions:

• Residue 10 of ET-1 is a key determinant for ETA/ETB receptor selectivity and activation.
• [Ala10]-ET-1 serves as a valuable tool for studying ETB receptor pharmacology.
• FCE27037 is a novel ETB antagonist capable of distinguishing functionally distinct ETB receptors.